Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC) — Las Palmas, Las Palmas

Public research footprint of Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Myeloid Leukemia, BCR/ABL-Positive · Chronic Pelvic Pain Syndrome (CPPS) · Chemotherapy Induced Peripheral Neuropathy (CIPN) · Chronic Myeloid Leukemia, Chronic Phase

Recently updated registry entries

NCT04230239 — Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With… (Completed)
NCT07611747 — Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in… (Recruiting)
NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.